FACESCAPE
ActiveSummary
FACESCAPE has been active since 1997 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €632,998 and a net result of €146,651. Equity has been growing by about 13% per year since 2018. The computed 12-month bankruptcy probability is 0.2% (very low).
Overview
Overview
Official details
Source: KBO- Status
- Active since 13-03-1997 Normal situation
- Activity
- “La société a pour objet l'exercice,en son nom et pour son compte,de la médecine…” (deed in French)From the articles, 7 activitiesNo NACE code in the KBO yet
- Financial year end
- 31 December
- Peppol
- Reachable since 26-03-2025
Financial position
- Bankruptcy probabilitywithin 12 months
- 0.2%
Annual accounts 2025
- Gross margin
- €257,914
- ▼ 11.1%
- Turnover
- ≈ €510,000
- estimated
- Profit
- €146,651
- ▼ 22.7%
- Equity
- €632,998
- ▲ 30.2%
- Total assets
- €1.0m
- ▲ 13.7%
Score breakdownraises risk2 of the last 3 accounts lateNo registered site in the KBOlowers riskSize: total assets €1.0mLiquidity: current ratio 6.38, cash €130,944Show the evidence
Checked score
Score 2025
92
/ 100
Excellent
Probability in this band: under 0.55%
Financially stronger than 66% of micro companies without a NACE code
Financial strength · tick: 2024
Strong
Solvency
85+7
equity 60.4% of total assets
Liquidity
65+1
short-term debt 11.7% · cash 12.5%
Profitability
86+10
return on assets 14.0%
Bankruptcy probability within 12 months
0.2%
Very low
0%0.5%1.5%4%10%≥ 25%
About 2 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
Last 24 months
12-2024: 0.2%
01-2025: 0.2%● unchanged vs 12-2024
02-2025: 0.2%● unchanged vs 01-2025
03-2025: 0.2%● unchanged vs 02-2025
04-2025: 0.2%● unchanged vs 03-2025
05-2025: 0.2%● unchanged vs 04-2025
06-2025: 0.2%● unchanged vs 05-2025
07-2025: 0.3%▲ +0.1 percentage points vs 06-2025
08-2025: 0.4%▲ +0.1 percentage points vs 07-2025
09-2025: 0.5%▲ +0.1 percentage points vs 08-2025
10-2025: 0.7%▲ +0.2 percentage points vs 09-2025highest value
11-2025: 0.2%▼ -0.5 percentage points vs 10-2025
12-2025: 0.2%● unchanged vs 11-2025
01-2026: 0.2%● unchanged vs 12-2025
02-2026: 0.3%▲ +0.1 percentage points vs 01-2026
03-2026: 0.2%▼ -0.1 percentage points vs 02-2026
04-2026: 0.2%● unchanged vs 03-2026
05-2026: 0.2%● unchanged vs 04-2026
06-2026: 0.2%● unchanged vs 05-2026
07-2026: 0.2%● unchanged vs 06-2026
08-2026: 0.2%● unchanged vs 07-2026lowest value
09-2026: 0.2%● unchanged vs 08-2026lowest value
10-2026: 0.2%● unchanged vs 09-2026lowest value
11-2026: 0.2%● unchanged vs 10-2026lowest value
Credit of up to €55,000 on 30-day terms is acceptable
Liquidity is ample, with a current ratio of 6.38 (4.06 in 2024), above the usual 1.5. Short-term debt is 11.7% and cash 12.5% of total assets. 39.6% of the assets are financed with debt and provisions.
Calculation
The band follows from the bankruptcy probability. 10 more points roughly halve it.
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (no NACE code, micro). It does better than 51% of them on solvency, 61% on liquidity, 69% on profitability and 81% on growth.
The bankruptcy probability was computed on 04-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
Five signals.
lowers riskraises riskneutral
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 29-07-2026, 2 days ahead of the deadline.
NBB · 10 filingsDeviation from the deadline
2025
2 days early
2024
61 days late
2023
61 days late
2022
31 days late
2021
26 days early
2020
90 days late
2019
61 days late
← before the deadline
after the deadline →
tick = median of all Belgian filings
The company filed its last 7 accounts on average 39 days after the deadline. The Belgian median for financial year 2024 was 4 days before the deadline, and 38% of all filings were late.
Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 31 August (4 of the last 5 accounts filed within 33 days either side of that date).
Companies Code · seven monthsWhere today falls in the filing period
04-11-2026 today31-12-2026 year end31-07-2027 deadline
Financials
Financials · financial year 2025, micro format
Annual accounts 2025 filed on 29-07-2026 at the NBB all 29 filings
Turnover
≈ €510,000
Estimated: probably between €360,000 and €750,000
Total assets
€1.0m▲ 13.7%
2024 · €921,174
Net result
€146,651▼ 22.7%
2024 · €189,762
Working capital
€661,792▲ 32.2%
2024 · €500,772
Multi-year overview
2018 to 2025, 8 financial yearsOperating result
€238,459
▼ 32.9%
2025
20182025
Net result
€146,651
▼ 22.7%
2025
20182025
Equity
€632,998
▲ 30.2%
2025
20182025
Total assets
€1.0m
▲ 13.7%
2025
20182025
Debt
€414,431
▼ 4.7%
2025
20182025
Working capital
€661,792
▲ 32.2%
2025
20182025
Every figure per financial year
Every figure with its change against the financial year before
favourable
unfavourable
Line20182019202020212022202320242025
Operating result€0.2m-€0.1m▼ 31.0%€0.01m▼ 91.2%€0.2m▲ 15×€0.1m▼ 33.0%€0.2m▲ 48.7%€0.4m▲ 123%€0.2m▼ 32.9%
Net result€0.03m-€0.03m▼ 20.2%-€0.07m€0.05m-€0.01m€0.04m€0.2m▲ 421%€0.1m▼ 22.7%
Equity€0.3m-€0.3m▲ 10.3%€0.2m▼ 24.2%€0.3m▲ 20.3%€0.3m▼ 3.7%€0.3m▲ 14.0%€0.5m▲ 64.0%€0.6m▲ 30.2%
Total assets€0.6m-€0.7m▲ 5.7%€0.6m▼ 8.2%€0.6m▲ 4.0%€0.7m▲ 9.0%€0.7m▲ 9.7%€0.9m▲ 23.1%€1.0m▲ 13.7%
Debt€0.3m-€0.3m▼ 1.1%€0.3m▲ 0.7%€0.3m▼ 1.0%€0.3m▲ 18.3%€0.4m▲ 12.6%€0.4m▲ 17.4%€0.4m▼ 4.7%
Working capital€0.3m-€0.3m▲ 9.4%€0.3m▼ 13.2%€0.3m▲ 17.0%€0.3m▲ 8.1%€0.4m▲ 13.4%€0.5m▲ 31.8%€0.7m▲ 32.2%
The operating result for 2025 is 33% lower than in 2024.
Turnover and EBIT margin are not published. The micro format does not require them. The turnover shown is an estimate from the gross margin.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €1.0m
Fixed assets
€262,611 ▲ 2.2%
Current assets
€784,818 ▲ 18.2%
Equity and liabilities €1.0m
Equity
€632,998 ▲ 30.2%
Debt
€414,431 ▼ 4.7%
Debt's share of the balance-sheet total falls from 47.2% to 39.6%. Equity is higher and debt is lower.
Key figures and ratios
EBITDA
€257,126▼
2024 · €370,225
Cash flow
€165,317▼
2024 · €204,667
Current ratio
6.38▲
2024 · 4.06
Debt to equity
0.65▼
2024 · 0.89
ROE
23.2%▼
2024 · 39.0%
ROA
14.0%▼
2024 · 20.6%
Interest coverage
11.07▲
2024 · 3.75
Debt ≤ 1 year
€123,026▼
2024 · €163,465
Debt > 1 year
€250,000=
2024 · €250,000
Income taxes
€68,584▲
2024 · €66,948
Green means a favourable move, even when the figure itself falls, as with debt or debt to equity.
Investments
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Tangible fixed assets | - | - | - | €2,233 | €24,340 |
| Depreciation and write-downs of the year | €19,622 | €19,538 | €19,379 | €14,905 | €18,667 |
Source: notes to the 2021 to 2025 annual accounts (statement of fixed assets)
Annual accounts
| Line | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|---|---|---|
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630 | €19,260 | €21,409 | €19,622 | €19,622 | €19,538 | €19,379 | €14,905 | €18,667 | ▲ 25.2% |
| Provisions for liabilities and charges: additions (uses and reversals)635/8 | - | - | - | -€18,588 | €15,577 | -€11,596 | -€81,566 | - | - |
| Other operating charges640/8 | - | - | - | €348 | €3,364 | €360 | €1,570 | €788 | ▼ 49.8% |
| Gross operating margin9900 | €151,079 | €159,661 | €48,172 | €161,016 | €145,431 | €167,159 | €290,229 | €257,914 | ▼ 11.1% |
| Operating profit (loss)9901 | €181,661 | €125,347 | €10,984 | €159,636 | €106,950 | €159,015 | €355,320 | €238,459 | ▼ 32.9% |
| Financial income75/76B | - | - | - | - | €2,165 | - | - | €5 | - |
| Recurring financial income75 | €2 | - | €0 | - | €2,165 | - | - | €5 | - |
| Financial charges65/66B | - | - | - | €114,015 | €119,115 | €117,283 | €98,609 | €23,229 | ▼ 76.4% |
| Recurring financial charges65 | €154,657 | €97,672 | €79,892 | €114,015 | €119,115 | €117,283 | €98,609 | €23,229 | ▼ 76.4% |
| Profit (loss) for the period before taxes9903 | €34,736 | €27,675 | -€68,907 | €45,621 | -€10,000 | €41,732 | €256,711 | €215,235 | ▼ 16.2% |
| Income taxes67/77 | €148 | €58 | €2,809 | - | - | €5,339 | €66,948 | €68,584 | ▲ 2.4% |
| Profit (loss) for the period9904 | €34,589 | €27,617 | -€71,716 | €45,621 | -€10,000 | €36,393 | €189,762 | €146,651 | ▼ 22.7% |
| Profit (loss) for the period to be appropriated9905 | €34,589 | €27,617 | -€52,966 | €45,621 | -€10,000 | €36,393 | €189,762 | €146,651 | ▼ 22.7% |
| Line | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||
| Total assets20/58 | €0.6m | €0.7m | €0.6m | €0.6m | €0.7m | €0.7m | €0.9m | €1.0m | ▲ 13.7% |
| Fixed assets21/28 | €0.3m | €0.3m | €0.3m | €0.3m | €0.3m | €0.3m | €0.3m | €0.3m | ▲ 2.2% |
| Intangible fixed assets21 | - | - | - | - | - | €0 | €0 | €0 | - |
| Tangible fixed assets22/27 | €0.3m | €0.3m | €0.3m | €0.3m | €0.3m | €0.3m | €0.3m | €0.3m | ▲ 2.2% |
| Land and buildings22 | - | - | - | €0.3m | €0.3m | €0.3m | €0.2m | €0.2m | ▼ 4.7% |
| Plant, machinery and equipment23 | - | - | - | €0.005m | €0.004m | €0.004m | €0.005m | €0.006m | ▲ 11.8% |
| Furniture and vehicles24 | - | - | - | €0.009m | €0.004m | €0 | €0 | €0.02m | - |
| Other tangible fixed assets26 | - | - | - | €0.02m | €0.01m | €0.01m | €0.008m | €0.005m | ▼ 31.3% |
| Current assets29/58 | €0.3m | €0.3m | €0.3m | €0.3m | €0.4m | €0.5m | €0.7m | €0.8m | ▲ 18.2% |
| Amounts receivable within one year40/41 | €0.3m | €0.2m | €0.2m | €0.1m | €0.09m | €0.1m | €0.1m | €0.09m | ▼ 18.5% |
| Trade receivables40 | - | - | - | €0.1m | €0.09m | €0.1m | €0.1m | €0.09m | ▼ 18.5% |
| Other amounts receivable41 | - | - | - | €0.03m | €0.005m | €0.005m | - | - | - |
| Current investments50/53 | €0.02m | €0.02m | €0.02m | €0.02m | €0.02m | €0.02m | €0.4m | €0.6m | ▲ 35.9% |
| Cash at bank and in hand54/58 | €0.005m | €0.08m | €0.08m | €0.2m | €0.3m | €0.4m | €0.1m | €0.1m | ▼ 5.1% |
| Deferred charges and accrued income490/1 | - | - | - | €0.002m | - | - | €0.001m | €0.001m | ▼ 24.5% |
| Equity and liabilities | |||||||||
| Total equity and liabilities10/49 | €0.6m | €0.7m | €0.6m | €0.6m | €0.7m | €0.7m | €0.9m | €1.0m | ▲ 13.7% |
| Equity10/15 | €0.3m | €0.3m | €0.2m | €0.3m | €0.3m | €0.3m | €0.5m | €0.6m | ▲ 30.2% |
| Contributions10/11 | €0.2m | €0.2m | - | €0.2m | €0.2m | €0.2m | €0.2m | €0.2m | = |
| Reserves13 | €0.1m | €0.1m | €0.09m | €0.09m | €0.09m | €0.1m | €0.3m | €0.4m | ▲ 48.4% |
| Non-distributable reserves130/1 | - | - | - | €0.01m | €0.01m | - | - | - | - |
| Reserves not available under the articles1311 | - | - | - | €0.01m | €0.01m | - | - | - | - |
| Distributable reserves133 | - | - | - | €0.08m | €0.08m | €0.1m | €0.3m | €0.4m | ▲ 48.4% |
| Profit (loss) carried forward14 | -€0.02m | €0.004m | -€0.05m | -€0.003m | -€0.01m | - | - | - | - |
| Provisions and deferred taxes16 | €0.07m | €0.08m | €0.1m | €0.08m | €0.09m | €0.08m | - | - | - |
| Provisions for liabilities and charges160/5 | - | - | - | €0.08m | €0.09m | €0.08m | - | - | - |
| Other liabilities and charges164/5 | - | - | - | €0.08m | €0.09m | €0.08m | - | - | - |
| Amounts payable17/49 | €0.3m | €0.3m | €0.3m | €0.3m | €0.3m | €0.4m | €0.4m | €0.4m | ▼ 4.7% |
| Amounts payable after more than one year17 | €0.3m | €0.3m | €0.3m | €0.3m | €0.3m | €0.3m | €0.3m | €0.3m | = |
| Financial debts170/4 | - | - | - | €0.3m | €0.3m | €0.3m | €0.3m | €0.3m | = |
| Amounts payable within one year42/48 | €0.01m | €0.007m | €0.008m | €0.007m | €0.06m | €0.1m | €0.2m | €0.1m | ▼ 24.7% |
| Trade debts44 | €0.004m | €0.004m | €467 | €0.002m | €0.001m | €345 | €0.001m | €85 | ▼ 88.4% |
| Suppliers440/4 | - | - | - | €0.002m | €0.001m | €345 | €0.001m | €85 | ▼ 88.4% |
| Taxes, remuneration and social security45 | - | - | - | €0.005m | €0.003m | €0.02m | €0.07m | €0.08m | ▲ 22.2% |
| Taxes450/3 | - | - | - | €0.005m | €0.003m | €0.02m | €0.07m | €0.08m | ▲ 22.2% |
| Other amounts payable47/48 | - | - | - | - | €0.05m | €0.08m | €0.1m | €0.04m | ▼ 57.0% |
| Accrued charges and deferred income492/3 | - | - | - | €0.02m | €0.02m | €0.02m | €0.02m | €0.04m | ▲ 93.8% |
| Line | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|---|---|---|
| Profit (loss) for the period9904 | €34,589 | €27,617 | -€71,716 | €45,621 | -€10,000 | €36,393 | €189,762 | €146,651 | ▼ 22.7% |
| + Depreciation and write-downs630 | €19,260 | €21,409 | €19,622 | €19,622 | €19,538 | €19,379 | €14,905 | €18,667 | ▲ 25.2% |
| Operating cash flow (approximation) | €53,848 | €49,026 | -€52,094 | €65,242 | €9,538 | €55,773 | €204,667 | €165,317 | ▼ 19.2% |
| Investment in fixed assets (approximation) | - | -€33,581 | -€4,355 | €0 | €0 | €0 | -€2,233 | -€24,340 | ▼ 990% |
| Change in cash | - | €76,646 | -€4,040 | €92,906 | €114,486 | €67,848 | -€215,236 | -€7,027 | ▲ 96.7% |
A Belgian filing has no cash-flow statement. These rows are therefore an approximation, derived from the income statement and the balance-sheet moves.
Historical observation
In July 2024, 20,136 companies had the same profile as FACESCAPE has now. Two years later, 95.0% were still going and 0.2% had gone bankrupt.
- Small
- 20 years or older
- solvency 30% or more
- a profit of 5% of the balance sheet or more
95.0%
was still going
4.7%
stopped otherwise
0.2%
went bankrupt
That fits the bankruptcy probability of FACESCAPE itself: 0.2% within 12 months.
Test of the method
The method was tested on the 497,446 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 3.0% | 3.1% |
| 10 | 5.6% | 6.2% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 20,136 companies, not a prediction for FACESCAPE. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Latest 10 of 29 filings with the National Bank
| Financial year | Type | Filed | Reference | Document |
|---|---|---|---|---|
| 31-12-2025 | micro format | 29-07-2026 | 2026-00349825 | |
| 31-12-2024 | micro format | 30-09-2025 | 2025-00524367 | |
| 31-12-2023 | micro format | 30-09-2024 | 2024-00485363 | |
| 31-12-2022 | micro format | 31-08-2023 | 2023-00411097 | |
| 31-12-2021 | micro format | 05-07-2022 | 2022-20151799 | |
| 31-12-2020 | micro format | 29-10-2021 | 2021-75100414 | |
| 31-12-2019 | micro format | 30-09-2020 | 2020-57600581 | |
| 31-12-2018 | micro format | 27-08-2019 | 2019-51600305 | |
| 31-12-2017 | micro format | 30-08-2018 | 2018-58100562 | |
| 31-12-2016 | micro format | 31-08-2017 | 2017-56900114 |
Board & ownership
Directors
Directors
1 director, last change in 2023
Coulon Jean-Pol Pierre
Current
Director · listed in the 2025 annual accounts, filed on 29-07-2026
Owners and capital
Capital transactions
Capital over time
- 29-12-2023 Converted to unavailable equity
Mandate history
2 people, 1 in office
- Board
- mandate already running before its first mention
- end not dated
| Name | Functions and periods |
|---|---|
| Coulon Jean-Pol Pierre |
|
| JeanPol COULON |
|
Network & group
FACESCAPE shares no director with another company.
Connections & network
1 current directorThe network starts from the directors of FACESCAPE. Every other company they run is a node.
This company
Company
Director
Shareholding
+N: links not shown yet
Click a node to look further, drag to arrange, zoom with the mouse wheel.
Timeline
Acts, filings and financial milestones
Deadline for the 2026 accounts:
2026
29-07
micro format · 2 days before the deadline
2025
31-12
Financial
Equity above €500,000equity €632,998 ▲30.2%
After 3 profitable years in a row, equity reaches €632,998.
30-09
micro format · 61 days late
2024
31-12
Financial
Highest result from 2018 to 2025net €189,762 ▲421%
The operating result of €355,320 and the net result of €189,762 are both a record.
30-09
micro format · 61 days late
2023
31-12
Financial
Back to profitnet €36,393
The net result is €36,393, after one loss-making year.
29-12
Gazette deed
Registered office moved within TournaiNew seat: rue de la buissonnière 6 bte 2, 7536 Tournai (Vaulx) · Previous seat: Rue de la Bruyère 8, 7540 Tournai (Kain) · Change of role: JeanPol COULON, from manager to director6 points ▸
Gazette deed
Registered office moved within Tournai
New seat: rue de la buissonnière 6 bte 2, 7536 Tournai (Vaulx) · Previous seat: Rue de la Bruyère 8, 7540 Tournai (Kain) · Change of role: JeanPol COULON, from manager to director6 points ▸
- General meeting, 21-12-2023
- Amendment of the articles, 3
- Director appointment, JeanPol COULON (director (not named in the articles))
- Director resignation, JeanPol COULON (manager)
- Director discharge, JeanPol COULON
- Registered-office move, rue de la buissonnière 6 bte 2, 7536 Tournai (Vaulx)
- The act holds 4 more points.
31-08
micro format · 31 days late
2022
05-07
micro format · 26 days before the deadline
2021
31-12
Financial
Back to profitnet €45,621
The net result is €45,621, after one loss-making year.
29-10
micro format · 90 days late
2020
31-12
Financial
Weakest financial yearnet -€71,716
The net result drops to -€71,716, the lowest from 2018 to 2025. It recovers the following year.
Show earlier events
30-09
micro format · 61 days late
2019
27-08
micro format · 27 days late
2018
30-08
micro format · 30 days late
2017
31-08
micro format · 31 days late
1997
22-03
Gazette deed
Incorporation
Financial milestoneGazette deedNBB filingFinancial milestones sit on the financial year-end date, not the filing date.
Sources:Publications in the Belgian Official GazetteFilings with the National Bank
History
Company details
Register details
Identity
KBO recordName
FACESCAPE in French
Enterprise number
0460.200.959
LEI code
549300LWKO2F57ZAWM45
no longer live in the LEI register
Legal form
Private limited company
Status
Active, normale toestand
Founded
13-03-1997
Entity type
Legal entity
Registered office clauseThe articles name the region of the registered office. The language of official documents depends on that region, among other things.
“Région Wallonne”
deed of 29-12-2023 (in French)Registered office and establishments
Registered office
Rue de la Buissonnière(VAU) 6, 7536 Tournai, Belgium
1 former office
- 7540 Tournai (Kain) until the act of 29-12-2023
E-mail
jeanpol.coulon@gmail.com
Phone
0477647661
Activities
PurposeThe purpose describes the activities the company may carry out under its articles.
deed of 29-12-2023 (in French)
“La société a pour objet l'exercice,en son nom et pour son compte,de la médecine et plus particulièrement de la stomatologie,et ce par ses…”
7 activities
- La société a pour objet l'exercice,en son nom et pour son compte,de la médecine et plus particulièrement de la stomatologie,et ce par ses organes médecins légalement habilités exercer l'art de guérir en Belgique inscrits au tableau de l'Ordre des Médecins et qui apportent la Société la totalité de leur activité médicale.
- Elle pourra de plus faire toutes opérations généralement quelconques ayant un rapport direct ou indirect avec son objet et ne modifiant pas le caractère civil de la société et sa vocation médicale.
- La société pourra s'intéresser par voie d'apport,de fusion,de souscription ou de toute autre manière,dans toutes entreprises,associations ou sociétés ayant un objet similaire,analogue ou connexe,ou de nature à favoriser celui de la société sous réserve de l'accord du Conseil Provincial de l'Ordre des Médecins compétent et pour autant que cette participation fasse l'objet également d'un contrat.
- A titre accessoire,la société pourra également avoir pour objet la constitution,au départ de ses bénéfices réservés la gestion et la valorisation d'un patrimoine immobilier,notamment par l'achat,la vente,la location,la mise en location,la construction,le tout au sens le plus large,pour autant que n'en soient altérés,ni son caractère civil,ni sa vocation prioritairement médicale,et que ces opérations s'inscrivant dans les limites d'une gestion raisonnable n'aient pas un caractère répétitif et commercial.
- Dès lors qu'il y a plusieurs actionnaires,un accord préalable des actionnaires est à prévoir sur la politique de constitution et de gestion des investissements ainsi réalisés.Cet accord fera l'objet d'un écrit soumis au Conseil provincial intéressé de l'Ordre des Médecins.
- La société garantit à chaque médecin actionnaire qu'il pourra exercer sa profession en toute indépendance dans le respect des règles relatives au secret médical,à la liberté diagnostique et thérapeutique,et au libre choix du patient
- Elle s’interdit toute forme de commercialisation de la médecine,de collusion directe ou indirecte,de dichotomie et de surconsommation.
Invoicing and payment
VAT number
BE 0460.200.959
Financial year and general meeting
Accounts at the NBBFinancial year end
31-12
Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
First Friday of June at 17:00
deed of 29-12-2023 (in French)Sites & property
Location